The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Monday 14 September 2015
Target Ovarian Cancer is proud to announce the launch of a new grants round for our UK wide ovarian cancer research programme. We are now seeking outline project proposals for our 'Innovation in ovarian cancer research award' and for our 'Supportive and palliative care research award’ from...
Friday 4 September 2015
Today, NHS England has announced a significant cut to the list of drugs that the Cancer Drugs Fund will fund. The drug bevacizumab (Avastin) was delisted for use in cervical, breast and colorectal cancers, but it is still available for use in ovarian cancer. Dr Simon Newman, Director of Research...
Monday 13 July 2015
Today, the Scottish Medicines Consortium (SMC) has announced that it has rejected olaparib (Lynparza).   This decision comes after both the Cancer Drugs Fund and NICE rejected the drug on cost grounds in England and Wales. Olaparib was being assessed as a maintenance treatment of relapsed platinum-...
Friday 10 July 2015
The All Party Parliamentary Group (APPG) on Ovarian Cancer held their Annual General Meeting (AGM) on 10 June. Set up in 2011, the APPG has over 60 members and meets several times during the year. Target Ovarian Cancer provides secretariat duties for the group. The purpose of the APPG is to provide...